Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial
Anxiety is common among patients with coronary heart disease (CHD) and is associated with a worse prognosis. UNWIND was a 12-week randomized clinical trial comparing exercise and escitalopram to placebo on measures of anxiety, depression, and CHD biomarkers. Primary results of the trial reported tha...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-09-01
|
| Series: | Journal of Cardiovascular Development and Disease |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2308-3425/9/10/320 |
| _version_ | 1797431491909648384 |
|---|---|
| author | James A. Blumenthal Patrick J. Smith Wei Jiang Alan Hinderliter Lana L. Watkins Benson M. Hoffman William E. Kraus Stephanie Mabe Lawrence Liao Jonathan Davidson Andrew Sherwood |
| author_facet | James A. Blumenthal Patrick J. Smith Wei Jiang Alan Hinderliter Lana L. Watkins Benson M. Hoffman William E. Kraus Stephanie Mabe Lawrence Liao Jonathan Davidson Andrew Sherwood |
| author_sort | James A. Blumenthal |
| collection | DOAJ |
| description | Anxiety is common among patients with coronary heart disease (CHD) and is associated with a worse prognosis. UNWIND was a 12-week randomized clinical trial comparing exercise and escitalopram to placebo on measures of anxiety, depression, and CHD biomarkers. Primary results of the trial reported that treatment with escitalopram, but not exercise, was associated with significant reductions in anxiety and depression. At 1-year follow-up, participants completed the Hospital Anxiety-Depression Scale-Anxiety (HADS-A) along with the HADS-Depression (HADS-D), the Beck Depression Inventory-II (BDI-II), and the Godin Leisure Time Exercise survey to assess physical activity. Results showed that those patients randomized to escitalopram had lower scores on the HADS-A compared to those randomized to exercise (<i>P</i> = 0.006) and had less depression compared to exercise on the HADS-D (<i>P</i> = 0.004) and BDI-II (<i>P</i> = 0.004). Participants randomized to exercise reported higher levels of physical activity at 1-year compared to those randomized to Placebo (<i>P</i> = 0.039). However, despite reporting being more physically active, those randomized to exercise did not have less anxiety or depression compared to placebo controls. Escitalopram appears to be a safe and effective treatment for anxiety; exercise has many health benefits, but does not appear to be effective in treating anxiety. |
| first_indexed | 2024-03-09T09:45:52Z |
| format | Article |
| id | doaj.art-8299bf61133241e3bc2b821968120f0e |
| institution | Directory Open Access Journal |
| issn | 2308-3425 |
| language | English |
| last_indexed | 2024-03-09T09:45:52Z |
| publishDate | 2022-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Cardiovascular Development and Disease |
| spelling | doaj.art-8299bf61133241e3bc2b821968120f0e2023-12-02T00:33:16ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252022-09-0191032010.3390/jcdd9100320Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical TrialJames A. Blumenthal0Patrick J. Smith1Wei Jiang2Alan Hinderliter3Lana L. Watkins4Benson M. Hoffman5William E. Kraus6Stephanie Mabe7Lawrence Liao8Jonathan Davidson9Andrew Sherwood10Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USADepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USADepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USADepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27710, USADepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USADepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USADepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USADepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USADepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USADepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USADepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USAAnxiety is common among patients with coronary heart disease (CHD) and is associated with a worse prognosis. UNWIND was a 12-week randomized clinical trial comparing exercise and escitalopram to placebo on measures of anxiety, depression, and CHD biomarkers. Primary results of the trial reported that treatment with escitalopram, but not exercise, was associated with significant reductions in anxiety and depression. At 1-year follow-up, participants completed the Hospital Anxiety-Depression Scale-Anxiety (HADS-A) along with the HADS-Depression (HADS-D), the Beck Depression Inventory-II (BDI-II), and the Godin Leisure Time Exercise survey to assess physical activity. Results showed that those patients randomized to escitalopram had lower scores on the HADS-A compared to those randomized to exercise (<i>P</i> = 0.006) and had less depression compared to exercise on the HADS-D (<i>P</i> = 0.004) and BDI-II (<i>P</i> = 0.004). Participants randomized to exercise reported higher levels of physical activity at 1-year compared to those randomized to Placebo (<i>P</i> = 0.039). However, despite reporting being more physically active, those randomized to exercise did not have less anxiety or depression compared to placebo controls. Escitalopram appears to be a safe and effective treatment for anxiety; exercise has many health benefits, but does not appear to be effective in treating anxiety.https://www.mdpi.com/2308-3425/9/10/320anxietydepressionexerciseescitalopramcoronary heart disease |
| spellingShingle | James A. Blumenthal Patrick J. Smith Wei Jiang Alan Hinderliter Lana L. Watkins Benson M. Hoffman William E. Kraus Stephanie Mabe Lawrence Liao Jonathan Davidson Andrew Sherwood Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial Journal of Cardiovascular Development and Disease anxiety depression exercise escitalopram coronary heart disease |
| title | Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial |
| title_full | Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial |
| title_fullStr | Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial |
| title_full_unstemmed | Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial |
| title_short | Exercise and Escitalopram in the Treatment of Anxiety in Patients with Coronary Heart Disease: One Year Follow-Up of the UNWIND Randomized Clinical Trial |
| title_sort | exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease one year follow up of the unwind randomized clinical trial |
| topic | anxiety depression exercise escitalopram coronary heart disease |
| url | https://www.mdpi.com/2308-3425/9/10/320 |
| work_keys_str_mv | AT jamesablumenthal exerciseandescitalopraminthetreatmentofanxietyinpatientswithcoronaryheartdiseaseoneyearfollowupoftheunwindrandomizedclinicaltrial AT patrickjsmith exerciseandescitalopraminthetreatmentofanxietyinpatientswithcoronaryheartdiseaseoneyearfollowupoftheunwindrandomizedclinicaltrial AT weijiang exerciseandescitalopraminthetreatmentofanxietyinpatientswithcoronaryheartdiseaseoneyearfollowupoftheunwindrandomizedclinicaltrial AT alanhinderliter exerciseandescitalopraminthetreatmentofanxietyinpatientswithcoronaryheartdiseaseoneyearfollowupoftheunwindrandomizedclinicaltrial AT lanalwatkins exerciseandescitalopraminthetreatmentofanxietyinpatientswithcoronaryheartdiseaseoneyearfollowupoftheunwindrandomizedclinicaltrial AT bensonmhoffman exerciseandescitalopraminthetreatmentofanxietyinpatientswithcoronaryheartdiseaseoneyearfollowupoftheunwindrandomizedclinicaltrial AT williamekraus exerciseandescitalopraminthetreatmentofanxietyinpatientswithcoronaryheartdiseaseoneyearfollowupoftheunwindrandomizedclinicaltrial AT stephaniemabe exerciseandescitalopraminthetreatmentofanxietyinpatientswithcoronaryheartdiseaseoneyearfollowupoftheunwindrandomizedclinicaltrial AT lawrenceliao exerciseandescitalopraminthetreatmentofanxietyinpatientswithcoronaryheartdiseaseoneyearfollowupoftheunwindrandomizedclinicaltrial AT jonathandavidson exerciseandescitalopraminthetreatmentofanxietyinpatientswithcoronaryheartdiseaseoneyearfollowupoftheunwindrandomizedclinicaltrial AT andrewsherwood exerciseandescitalopraminthetreatmentofanxietyinpatientswithcoronaryheartdiseaseoneyearfollowupoftheunwindrandomizedclinicaltrial |